| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 9.076.288.044 $ | 99,88 | 181.834.752 | |||||||
| Vertex Pharmaceuticals, Inc. | Vertex Pharmaceuticals, Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 734.315.959 $ | 8,08 | 1.478.300 | |
| Amgen, Inc. | Amgen, Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 711.361.202 $ | 7,83 | 1.964.435 | |
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 621.785.595 $ | 6,84 | 4.921.526 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 445.868.512 $ | 4,91 | 715 | |
| Argenx SE | Argenx SE | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 341.583.575 $ | 3,76 | 368 | |
| Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 283.622.639 $ | 3,12 | 942 | |
| Natera, Inc. | Natera, Inc. | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 262.677.550 $ | 2,89 | 968 | |
| Revolution Medicines, Inc. | Revolution Medicines, Inc. | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 252.662.819 $ | 2,78 | 1.349.118 | |
| Biogen, Inc. | Biogen, Inc. | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 224.089.654 $ | 2,47 | 1.037.164 | |
| Illumina, Inc. | Illumina, Inc. | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 188.025.217 $ | 2,07 | 1.069.358 | |
| Moderna, Inc. | Moderna, Inc. | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 180.306.731 $ | 1,98 | 2.574.707 | |
| Insmed, Inc. | Insmed, Inc. | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 162.203.032 $ | 1,78 | 1.521.319 | |
| BeOne Medicines Ltd. | BeOne Medicines Ltd. | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 160.774.375 $ | 1,77 | 564 | |
| Incyte Corp. | Incyte Corp. | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 159.002.023 $ | 1,75 | 1.402.629 | |
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 157.564.164 $ | 1,73 | 291 | |
| Roivant Sciences Ltd. | Roivant Sciences Ltd. | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 129.587.174 $ | 1,43 | 3.661.689 | |
| Neurocrine Biosciences, Inc. | Neurocrine Biosciences, Inc. | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 117.983.095 $ | 1,30 | 700 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | DK0060615755 | Long | Börsenkurs (Stufe 1) | 116.859.367 $ | 1,29 | 438 | |
| Genmab A/S | Genmab A/S | EC | 372303206 | Long | Börsenkurs (Stufe 1) | 101.669.080 $ | 1,12 | 3.701.095 | |
| Exelixis, Inc. | Exelixis, Inc. | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 93.913.564 $ | 1,03 | 1.726.035 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 91.064.248 $ | 1,00 | 1.148.496 | |
| Bridgebio Pharma, Inc. | Bridgebio Pharma, Inc. | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 89.231.658 $ | 0,98 | 1.198.062 | |
| Medpace Holdings, Inc. | Medpace Holdings, Inc. | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 86.345.413 $ | 0,95 | 163 | |
| Madrigal Pharmaceuticals, Inc. | Madrigal Pharmaceuticals, Inc. | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 82.548.545 $ | 0,91 | 154 | |
| Bio-Techne Corp. | Bio-Techne Corp. | EC | 09073M104 | Long | Börsenkurs (Stufe 1) | 78.097.994 $ | 0,86 | 1.105.421 | |
| BioMarin Pharmaceutical, Inc. | BioMarin Pharmaceutical, Inc. | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 77.168.208 $ | 0,85 | 1.348.623 | |
| Charles River Laboratories International, Inc. | Charles River Laboratories International, Inc. | EC | 159864107 | Long | Börsenkurs (Stufe 1) | 76.488.783 $ | 0,84 | 337 | |
| Arrowhead Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 76.431.845 $ | 0,84 | 938 | |
| Axsome Therapeutics, Inc. | Axsome Therapeutics, Inc. | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 74.691.076 $ | 0,82 | 305 | |
| Cytokinetics, Inc. | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 71.932.817 $ | 0,79 | 844 | |
| Krystal Biotech, Inc. | Krystal Biotech, Inc. | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 67.753.583 $ | 0,75 | 182 | |
| Halozyme Therapeutics, Inc. | Halozyme Therapeutics, Inc. | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 65.110.856 $ | 0,72 | 832 | |
| Praxis Precision Medicines, Inc. | Praxis Precision Medicines, Inc. | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 61.940.167 $ | 0,68 | 185 | |
| Abivax SA | Abivax SA | EC | 00370M103 | Long | Börsenkurs (Stufe 1) | 61.142.886 $ | 0,67 | 459 | |
| Alkermes plc | Alkermes plc | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 60.513.396 $ | 0,67 | 1.154.946 | |
| BioNTech SE | BioNTech SE | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 60.215.726 $ | 0,66 | 647 | |
| Vaxcyte, Inc. | Vaxcyte, Inc. | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 58.157.263 $ | 0,64 | 1.000.469 | |
| Kymera Therapeutics, Inc. | Kymera Therapeutics, Inc. | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 57.802.166 $ | 0,64 | 504 | |
| Apogee Therapeutics, Inc. | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 53.579.783 $ | 0,59 | 404 | |
| Protagonist Therapeutics, Inc. | Protagonist Therapeutics, Inc. | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 52.998.198 $ | 0,58 | 432 | |
| Rhythm Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 52.218.519 $ | 0,57 | 470 | |
| Repligen Corp. | Repligen Corp. | EC | 759916109 | Long | Börsenkurs (Stufe 1) | 51.595.741 $ | 0,57 | 378 | |
| Spyre Therapeutics, Inc. | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 48.623.386 $ | 0,54 | 548 | |
| Bruker Corp. | Bruker Corp. | EC | 116794108 | Long | Börsenkurs (Stufe 1) | 47.394.097 $ | 0,52 | 788 | |
| PTC Therapeutics, Inc. | PTC Therapeutics, Inc. | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 46.321.237 $ | 0,51 | 568 | |
| Nuvalent, Inc. | Nuvalent, Inc., Class A | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 45.699.323 $ | 0,50 | 370 | |
| Twist Bioscience Corp. | Twist Bioscience Corp. | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 43.449.722 $ | 0,48 | 422 | |
| Tempus AI, Inc. | Tempus AI, Inc., Class A | EC | 88023B103 | Long | Börsenkurs (Stufe 1) | 43.369.179 $ | 0,48 | 749 | |
| Mirum Pharmaceuticals, Inc. | Mirum Pharmaceuticals, Inc. | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 41.143.549 $ | 0,45 | 351 | |
| Cogent Biosciences, Inc. | Cogent Biosciences, Inc. | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 40.348.388 $ | 0,44 | 1.042.594 | |
| Xenon Pharmaceuticals, Inc. | Xenon Pharmaceuticals, Inc. | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 38.806.832 $ | 0,43 | 643 | |
| Scholar Rock Holding Corp. | Scholar Rock Holding Corp. | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 37.592.720 $ | 0,41 | 684 | |
| Travere Therapeutics, Inc. | Travere Therapeutics, Inc. | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 36.382.317 $ | 0,40 | 640 | |
| Definium Therapeutics, Inc. | Definium Therapeutics, Inc. | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 34.969.536 $ | 0,38 | 743 | |
| CRISPR Therapeutics AG | CRISPR Therapeutics AG | EC | CH0334081137 | Long | Börsenkurs (Stufe 1) | 34.613.484 $ | 0,38 | 635 | |
| Oruka Therapeutics, Inc. | Oruka Therapeutics, Inc. | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 34.186.777 $ | 0,38 | 359 | |
| Veracyte, Inc. | Veracyte, Inc. | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 32.382.019 $ | 0,36 | 551 | |
| 10X Genomics, Inc. | 10X Genomics, Inc., Class A | EC | 88025U109 | Long | Börsenkurs (Stufe 1) | 30.646.542 $ | 0,34 | 799 | |
| Legend Biotech Corp. | Legend Biotech Corp. | EC | 52490G102 | Long | Börsenkurs (Stufe 1) | 30.401.572 $ | 0,33 | 1.052.686 | |
| ACADIA Pharmaceuticals, Inc. | ACADIA Pharmaceuticals, Inc. | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 30.258.876 $ | 0,33 | 1.196.003 | |
| CG oncology, Inc. | CG oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 28.943.567 $ | 0,32 | 407 | |
| Denali Therapeutics, Inc. | Denali Therapeutics, Inc. | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 27.114.950 $ | 0,30 | 1.054.236 | |
| Crinetics Pharmaceuticals, Inc. | Crinetics Pharmaceuticals, Inc. | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 25.904.032 $ | 0,29 | 692 | |
| Erasca, Inc. | Erasca, Inc. | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 24.275.777 $ | 0,27 | 1.325.097 | |
| Tango Therapeutics, Inc. | Tango Therapeutics, Inc. | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 23.490.921 $ | 0,26 | 751 | |
| Adaptive Biotechnologies Corp. | Adaptive Biotechnologies Corp. | EC | 00650F109 | Long | Börsenkurs (Stufe 1) | 23.481.637 $ | 0,26 | 1.094.715 | |
| ImmunityBio, Inc. | ImmunityBio, Inc. | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 23.337.013 $ | 0,26 | 2.665.564 | |
| Beam Therapeutics, Inc. | Beam Therapeutics, Inc. | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 22.804.233 $ | 0,25 | 664 | |
| Edgewise Therapeutics, Inc. | Edgewise Therapeutics, Inc. | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 22.594.059 $ | 0,25 | 556 | |
| Structure Therapeutics, Inc. | Structure Therapeutics, Inc. | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 22.233.388 $ | 0,24 | 414 | |
| Immunovant, Inc. | Immunovant, Inc. | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 22.106.472 $ | 0,24 | 574 | |
| Ideaya Biosciences, Inc. | Ideaya Biosciences, Inc. | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 21.942.601 $ | 0,24 | 589 | |
| Ultragenyx Pharmaceutical, Inc. | Ultragenyx Pharmaceutical, Inc. | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 21.214.203 $ | 0,23 | 635 | |
| Dyne Therapeutics, Inc. | Dyne Therapeutics, Inc. | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 20.777.211 $ | 0,23 | 935 | |
| Arcutis Biotherapeutics, Inc. | Arcutis Biotherapeutics, Inc. | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 20.519.641 $ | 0,23 | 783 | |
| Newamsterdam Pharma Co. NV | Newamsterdam Pharma Co. NV | EC | NL00150012L7 | Long | Börsenkurs (Stufe 1) | 19.186.485 $ | 0,21 | 566 | |
| GRAIL, Inc. | GRAIL, Inc. | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 19.180.252 $ | 0,21 | 281 | |
| Relay Therapeutics, Inc. | Relay Therapeutics, Inc. | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 19.007.882 $ | 0,21 | 1.015.921 | |
| uniQure NV | uniQure NV | EC | NL0010696654 | Long | Börsenkurs (Stufe 1) | 18.386.001 $ | 0,20 | 399 | |
| Arcus Biosciences, Inc. | Arcus Biosciences, Inc. | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 18.288.911 $ | 0,20 | 593 | |
| Tarsus Pharmaceuticals, Inc. | Tarsus Pharmaceuticals, Inc. | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 18.006.945 $ | 0,20 | 286 | |
| Vera Therapeutics, Inc. | Vera Therapeutics, Inc., Class A | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 17.785.809 $ | 0,20 | 414 | |
| Enliven Therapeutics, Inc. | Enliven Therapeutics, Inc. | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 16.905.231 $ | 0,19 | 333 | |
| Nurix Therapeutics, Inc. | Nurix Therapeutics, Inc. | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 16.867.372 $ | 0,19 | 695 | |
| Alumis, Inc. | Alumis, Inc. | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 16.718.678 $ | 0,18 | 594 | |
| Kodiak Sciences, Inc. | Kodiak Sciences, Inc. | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 15.992.612 $ | 0,18 | 410 | |
| Vericel Corp. | Vericel Corp. | EC | 92346J108 | Long | Börsenkurs (Stufe 1) | 15.927.553 $ | 0,18 | 358 | |
| Intellia Therapeutics, Inc. | Intellia Therapeutics, Inc. | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 15.883.058 $ | 0,17 | 939 | |
| Caris Life Sciences, Inc. | Caris Life Sciences, Inc. | EC | 142152107 | Long | Börsenkurs (Stufe 1) | 15.485.972 $ | 0,17 | 869 | |
| BioCryst Pharmaceuticals, Inc. | BioCryst Pharmaceuticals, Inc. | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 15.289.370 $ | 0,17 | 1.528.937 | |
| Agios Pharmaceuticals, Inc. | Agios Pharmaceuticals, Inc. | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 14.675.929 $ | 0,16 | 395 | |
| Disc Medicine, Inc. | Disc Medicine, Inc. | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 14.350.873 $ | 0,16 | 196 | |
| Summit Therapeutics, Inc. | Summit Therapeutics, Inc. | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 13.927.638 $ | 0,15 | 956 | |
| Aurinia Pharmaceuticals, Inc. | Aurinia Pharmaceuticals, Inc. | EC | 05156V102 | Long | Börsenkurs (Stufe 1) | 13.591.833 $ | 0,15 | 801 | |
| ADMA Biologics, Inc. | ADMA Biologics, Inc. | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 13.381.688 $ | 0,15 | 1.598.768 | |
| Biohaven Ltd. | Biohaven Ltd. | EC | VGG1110E1079 | Long | Börsenkurs (Stufe 1) | 13.247.724 $ | 0,15 | 890 | |
| Zymeworks, Inc. | Zymeworks, Inc. | EC | 98985Y108 | Long | Börsenkurs (Stufe 1) | 13.084.638 $ | 0,14 | 501 | |
| AnaptysBio, Inc. | AnaptysBio, Inc. | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 13.063.140 $ | 0,14 | 194 | |
| AbCellera Biologics, Inc. | AbCellera Biologics, Inc. | EC | 00288U106 | Long | Börsenkurs (Stufe 1) | 13.001.201 $ | 0,14 | 1.656.204 | |
| Sarepta Therapeutics, Inc. | Sarepta Therapeutics, Inc. | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 12.918.633 $ | 0,14 | 719 | |
| Syndax Pharmaceuticals, Inc. | Syndax Pharmaceuticals, Inc. | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 12.496.706 $ | 0,14 | 572 | |
| Trevi Therapeutics, Inc. | Trevi Therapeutics, Inc. | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 12.274.665 $ | 0,14 | 658 | |
| Recursion Pharmaceuticals, Inc. | Recursion Pharmaceuticals, Inc., Class A | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 12.247.344 $ | 0,13 | 3.337.151 | |
| Zai Lab Ltd. | Zai Lab Ltd. | EC | 98887Q104 | Long | Börsenkurs (Stufe 1) | 12.037.032 $ | 0,13 | 634 | |
| Amylyx Pharmaceuticals, Inc. | Amylyx Pharmaceuticals, Inc. | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 11.826.319 $ | 0,13 | 658 | |
| Mineralys Therapeutics, Inc. | Mineralys Therapeutics, Inc. | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 11.635.611 $ | 0,13 | 431 | |
| Fortrea Holdings, Inc. | Fortrea Holdings, Inc. | EC | 34965K107 | Long | Börsenkurs (Stufe 1) | 11.546.188 $ | 0,13 | 664 | |
| Taysha Gene Therapies, Inc. | Taysha Gene Therapies, Inc. | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 11.491.650 $ | 0,13 | 1.687.467 | |
| MBX Biosciences, Inc. | MBX Biosciences, Inc. | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 11.470.284 $ | 0,13 | 208 | |
| Stoke Therapeutics, Inc. | Stoke Therapeutics, Inc. | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 11.450.757 $ | 0,13 | 350 | |
| Iovance Biotherapeutics, Inc. | Iovance Biotherapeutics, Inc. | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 11.387.484 $ | 0,13 | 2.737.376 | |
| Novocure Ltd. | Novocure Ltd. | EC | JE00BYSS4X48 | Long | Börsenkurs (Stufe 1) | 11.130.720 $ | 0,12 | 735 | |
| Grifols SA | Grifols SA | EC | 398438408 | Long | Börsenkurs (Stufe 1) | 11.002.313 $ | 0,12 | 1.553.999 | |
| AtaiBeckley, Inc. | AtaiBeckley, Inc. | EC | 04650F101 | Long | Börsenkurs (Stufe 1) | 10.927.071 $ | 0,12 | 2.073.448 | |
| Absci Corp. | Absci Corp. | EC | 00091E109 | Long | Börsenkurs (Stufe 1) | 10.924.085 $ | 0,12 | 943 | |
| Compass Pathways plc | Compass Pathways plc | EC | 20451W101 | Long | Börsenkurs (Stufe 1) | 10.823.943 $ | 0,12 | 765 | |
| UroGen Pharma Ltd. | UroGen Pharma Ltd. | EC | IL0011407140 | Long | Börsenkurs (Stufe 1) | 10.686.499 $ | 0,12 | 290 | |
| Novavax, Inc. | Novavax, Inc. | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 10.462.756 $ | 0,12 | 1.110.696 | |
| Tyra Biosciences, Inc. | Tyra Biosciences, Inc. | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 10.045.865 $ | 0,11 | 315 | |
| Monte Rosa Therapeutics, Inc. | Monte Rosa Therapeutics, Inc. | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 10.039.080 $ | 0,11 | 415 | |
| Nuvation Bio, Inc. | Nuvation Bio, Inc., Class A | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 9.902.467 $ | 0,11 | 1.743.392 | |
| Vir Biotechnology, Inc. | Vir Biotechnology, Inc. | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 9.671.920 $ | 0,11 | 949 | |
| Immunocore Holdings plc | Immunocore Holdings plc | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 9.502.394 $ | 0,10 | 299 | |
| CareDx, Inc. | CareDx, Inc. | EC | 14167L103 | Long | Börsenkurs (Stufe 1) | 9.376.928 $ | 0,10 | 329 | |
| GH Research plc | GH Research plc | EC | IE000GID8VI0 | Long | Börsenkurs (Stufe 1) | 9.297.577 $ | 0,10 | 346 | |
| MannKind Corp. | MannKind Corp. | EC | 56400P706 | Long | Börsenkurs (Stufe 1) | 8.851.121 $ | 0,10 | 2.077.728 | |
| Lakefront Biotherapeutics NV | Lakefront Biotherapeutics NV | EC | 36315X101 | Long | Börsenkurs (Stufe 1) | 8.771.548 $ | 0,10 | 293 | |
| Rapport Therapeutics, Inc. | Rapport Therapeutics, Inc. | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 8.360.252 $ | 0,09 | 201 | |
| Sionna Therapeutics, Inc. | Sionna Therapeutics, Inc. | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 8.168.635 $ | 0,09 | 186 | |
| ArriVent Biopharma, Inc. | ArriVent Biopharma, Inc. | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 8.007.118 $ | 0,09 | 230 | |
| Xencor, Inc. | Xencor, Inc. | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 7.936.060 $ | 0,09 | 493 | |
| Bicara Therapeutics, Inc. | Bicara Therapeutics, Inc. | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 7.866.870 $ | 0,09 | 265 | |
| Inhibrx Biosciences, Inc. | Inhibrx Biosciences, Inc. | EC | 45720N103 | Long | Börsenkurs (Stufe 1) | 7.260.219 $ | 0,08 | 77 | |
| Maze Therapeutics, Inc. | Maze Therapeutics, Inc. | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 7.244.048 $ | 0,08 | 243 | |
| Pharvaris NV | Pharvaris NV | EC | NL00150005Y4 | Long | Börsenkurs (Stufe 1) | 7.168.503 $ | 0,08 | 207 | |
| WaVe Life Sciences Ltd. | WaVe Life Sciences Ltd. | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 6.926.223 $ | 0,08 | 1.192.121 | |
| Stevanato Group SpA | Stevanato Group SpA | EC | IT0005452658 | Long | Börsenkurs (Stufe 1) | 6.738.429 $ | 0,07 | 373 | |
| Mesoblast Ltd. | Mesoblast Ltd. | EC | 590717401 | Long | Börsenkurs (Stufe 1) | 6.702.830 $ | 0,07 | 495 | |
| MeiraGTx Holdings plc | MeiraGTx Holdings plc | EC | KYG596651029 | Long | Börsenkurs (Stufe 1) | 6.683.113 $ | 0,07 | 495 | |
| Corvus Pharmaceuticals, Inc. | Corvus Pharmaceuticals, Inc. | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 6.658.355 $ | 0,07 | 446 | |
| Kura Oncology, Inc. | Kura Oncology, Inc. | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 6.649.060 $ | 0,07 | 606 | |
| Septerna, Inc. | Septerna, Inc. | EC | 81734D104 | Long | Börsenkurs (Stufe 1) | 6.451.681 $ | 0,07 | 193 | |
| Precigen, Inc. | Precigen, Inc. | EC | 74017N105 | Long | Börsenkurs (Stufe 1) | 6.366.170 $ | 0,07 | 1.116.872 | |
| Olema Pharmaceuticals, Inc. | Olema Pharmaceuticals, Inc. | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 6.234.033 $ | 0,07 | 498 | |
| Janux Therapeutics, Inc. | Janux Therapeutics, Inc. | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 6.200.402 $ | 0,07 | 404 | |
| Replimune Group, Inc. | Replimune Group, Inc. | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 5.953.523 $ | 0,07 | 538 | |
| Zevra Therapeutics, Inc. | Zevra Therapeutics, Inc. | EC | 488445206 | Long | Börsenkurs (Stufe 1) | 5.903.606 $ | 0,06 | 412 | |
| Personalis, Inc. | Personalis, Inc. | EC | 71535D106 | Long | Börsenkurs (Stufe 1) | 5.857.810 $ | 0,06 | 437 | |
| Alto Neuroscience, Inc. | Alto Neuroscience, Inc. | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 5.845.728 $ | 0,06 | 222 | |
| Cullinan Therapeutics, Inc. | Cullinan Therapeutics, Inc. | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 5.807.770 $ | 0,06 | 319 | |
| Theravance Biopharma, Inc. | Theravance Biopharma, Inc. | EC | KYG8807B1068 | Long | Börsenkurs (Stufe 1) | 5.787.191 $ | 0,06 | 340 | |
| Annexon, Inc. | Annexon, Inc. | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 5.763.668 $ | 0,06 | 1.009.399 | |
| Zenas Biopharma, Inc. | Zenas Biopharma, Inc. | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 5.696.439 $ | 0,06 | 224 | |
| Geron Corp. | Geron Corp. | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 5.666.380 $ | 0,06 | 4.426.859 | |
| Solid Biosciences, Inc. | Solid Biosciences, Inc. | EC | 83422E204 | Long | Börsenkurs (Stufe 1) | 5.510.394 $ | 0,06 | 552 | |
| BioAge Labs, Inc. | BioAge Labs, Inc. | EC | 09077V100 | Long | Börsenkurs (Stufe 1) | 5.474.186 $ | 0,06 | 223 | |
| Arbutus Biopharma Corp. | Arbutus Biopharma Corp. | EC | 03879J100 | Long | Börsenkurs (Stufe 1) | 5.316.960 $ | 0,06 | 1.107.700 | |
| Castle Biosciences, Inc. | Castle Biosciences, Inc. | EC | 14843C105 | Long | Börsenkurs (Stufe 1) | 4.967.168 $ | 0,05 | 208 | |
| Rigel Pharmaceuticals, Inc. | Rigel Pharmaceuticals, Inc. | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 4.935.379 $ | 0,05 | 126 | |
| Ironwood Pharmaceuticals, Inc. | Ironwood Pharmaceuticals, Inc., Class A | EC | 46333X108 | Long | Börsenkurs (Stufe 1) | 4.700.553 $ | 0,05 | 1.116.521 | |
| ORIC Pharmaceuticals, Inc. | ORIC Pharmaceuticals, Inc. | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 4.664.633 $ | 0,05 | 431 | |
| Savara, Inc. | Savara, Inc. | EC | 805111101 | Long | Börsenkurs (Stufe 1) | 4.634.661 $ | 0,05 | 752 | |
| Maravai LifeSciences Holdings, Inc. | Maravai LifeSciences Holdings, Inc., Class A | EC | 56600D107 | Long | Börsenkurs (Stufe 1) | 4.625.200 $ | 0,05 | 741 | |
| Sana Biotechnology, Inc. | Sana Biotechnology, Inc. | EC | 799566104 | Long | Börsenkurs (Stufe 1) | 4.455.236 $ | 0,05 | 1.276.572 | |
| CytomX Therapeutics, Inc. | CytomX Therapeutics, Inc. | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 4.419.716 $ | 0,05 | 1.178.591 | |
| 4D Molecular Therapeutics, Inc. | 4D Molecular Therapeutics, Inc. | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 4.375.926 $ | 0,05 | 329 | |
| Phathom Pharmaceuticals, Inc. | Phathom Pharmaceuticals, Inc. | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 4.355.331 $ | 0,05 | 401 | |
| Candel Therapeutics, Inc. | Candel Therapeutics, Inc. | EC | 137404109 | Long | Börsenkurs (Stufe 1) | 4.228.171 $ | 0,05 | 411 | |
| Aclaris Therapeutics, Inc. | Aclaris Therapeutics, Inc. | EC | 00461U105 | Long | Börsenkurs (Stufe 1) | 4.116.334 $ | 0,05 | 778 | |
| REGENXBIO, Inc. | REGENXBIO, Inc. | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 4.027.424 $ | 0,04 | 336 | |
| OPKO Health, Inc. | OPKO Health, Inc. | EC | 68375N103 | Long | Börsenkurs (Stufe 1) | 3.992.190 $ | 0,04 | 2.661.460 | |
| Altimmune, Inc. | Altimmune, Inc. | EC | 02155H200 | Long | Börsenkurs (Stufe 1) | 3.938.968 $ | 0,04 | 1.295.713 | |
| Design Therapeutics, Inc. | Design Therapeutics, Inc. | EC | 25056L103 | Long | Börsenkurs (Stufe 1) | 3.845.243 $ | 0,04 | 266 | |
| Allogene Therapeutics, Inc. | Allogene Therapeutics, Inc. | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 3.751.729 $ | 0,04 | 1.803.716 | |
| Cytek Biosciences, Inc. | Cytek Biosciences, Inc. | EC | 23285D109 | Long | Börsenkurs (Stufe 1) | 3.691.329 $ | 0,04 | 833 | |
| Myriad Genetics, Inc. | Myriad Genetics, Inc. | EC | 62855J104 | Long | Börsenkurs (Stufe 1) | 3.562.269 $ | 0,04 | 624 | |
| ARS Pharmaceuticals, Inc. | ARS Pharmaceuticals, Inc. | EC | 82835W108 | Long | Börsenkurs (Stufe 1) | 3.541.341 $ | 0,04 | 442 | |
| Ginkgo Bioworks Holdings, Inc. | Ginkgo Bioworks Holdings, Inc., Class A | EC | 37611X209 | Long | Börsenkurs (Stufe 1) | 3.530.249 $ | 0,04 | 356 | |
| Contineum Therapeutics, Inc. | Contineum Therapeutics, Inc., Class A | EC | 21217B100 | Long | Börsenkurs (Stufe 1) | 3.362.622 $ | 0,04 | 205 | |
| Pacific Biosciences of California, Inc. | Pacific Biosciences of California, Inc. | EC | 69404D108 | Long | Börsenkurs (Stufe 1) | 3.354.577 $ | 0,04 | 1.996.772 | |
| C4 Therapeutics, Inc. | C4 Therapeutics, Inc. | EC | 12529R107 | Long | Börsenkurs (Stufe 1) | 3.303.684 $ | 0,04 | 707 | |
| Aura Biosciences, Inc. | Aura Biosciences, Inc. | EC | 05153U107 | Long | Börsenkurs (Stufe 1) | 3.237.401 $ | 0,04 | 456 | |
| Sagimet Biosciences, Inc. | Sagimet Biosciences, Inc., Class A | EC | 786700104 | Long | Börsenkurs (Stufe 1) | 3.195.025 $ | 0,04 | 413 | |
| Arvinas, Inc. | Arvinas, Inc. | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 3.187.841 $ | 0,04 | 384 | |
| Cabaletta Bio, Inc. | Cabaletta Bio, Inc. | EC | 12674W109 | Long | Börsenkurs (Stufe 1) | 3.132.743 $ | 0,03 | 1.007.313 | |
| Prothena Corp. plc | Prothena Corp. plc | EC | IE00B91XRN20 | Long | Börsenkurs (Stufe 1) | 3.121.855 $ | 0,03 | 319 | |
| Alvotech SA | Alvotech SA | EC | LU2458332611 | Long | Börsenkurs (Stufe 1) | 3.095.836 $ | 0,03 | 839 | |
| Emergent BioSolutions, Inc. | Emergent BioSolutions, Inc. | EC | 29089Q105 | Long | Börsenkurs (Stufe 1) | 2.879.125 $ | 0,03 | 344 | |
| Enanta Pharmaceuticals, Inc. | Enanta Pharmaceuticals, Inc. | EC | 29251M106 | Long | Börsenkurs (Stufe 1) | 2.838.741 $ | 0,03 | 195 | |
| Neurogene, Inc. | Neurogene, Inc. | EC | 64135M105 | Long | Börsenkurs (Stufe 1) | 2.780.117 $ | 0,03 | 88 | |
| Fulgent Genetics, Inc. | Fulgent Genetics, Inc. | EC | 359664109 | Long | Börsenkurs (Stufe 1) | 2.645.397 $ | 0,03 | 129 | |
| Rocket Pharmaceuticals, Inc. | Rocket Pharmaceuticals, Inc. | EC | 77313F106 | Long | Börsenkurs (Stufe 1) | 2.497.975 $ | 0,03 | 730 | |
| Prime Medicine, Inc. | Prime Medicine, Inc. | EC | 74168J101 | Long | Börsenkurs (Stufe 1) | 2.472.377 $ | 0,03 | 670 | |
| Vanda Pharmaceuticals, Inc. | Vanda Pharmaceuticals, Inc. | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 2.463.373 $ | 0,03 | 403 | |
| Kyverna Therapeutics, Inc. | Kyverna Therapeutics, Inc. | EC | 501976104 | Long | Börsenkurs (Stufe 1) | 2.371.940 $ | 0,03 | 266 | |
| BridgeBio Oncology Therapeutics, Inc. | BridgeBio Oncology Therapeutics, Inc., Class A | EC | 107924102 | Long | Börsenkurs (Stufe 1) | 2.331.903 $ | 0,03 | 306 | |
| Tectonic Therapeutic, Inc. | Tectonic Therapeutic, Inc. | EC | 878972108 | Long | Börsenkurs (Stufe 1) | 2.287.759 $ | 0,03 | 67 | |
| Autolus Therapeutics plc | Autolus Therapeutics plc | EC | 05280R100 | Long | Börsenkurs (Stufe 1) | 2.286.286 $ | 0,03 | 1.428.929 | |
| Editas Medicine, Inc. | Editas Medicine, Inc. | EC | 28106W103 | Long | Börsenkurs (Stufe 1) | 2.227.393 $ | 0,02 | 687 | |
| Standard BioTools, Inc. | Standard BioTools, Inc. | EC | 34385P108 | Long | Börsenkurs (Stufe 1) | 2.179.188 $ | 0,02 | 2.648.825 | |
| Perspective Therapeutics, Inc. | Perspective Therapeutics, Inc. | EC | 46489V302 | Long | Börsenkurs (Stufe 1) | 2.169.568 $ | 0,02 | 636 | |
| Silence Therapeutics plc | Silence Therapeutics plc | EC | 82686Q101 | Long | Börsenkurs (Stufe 1) | 2.039.831 $ | 0,02 | 186 | |
| OmniAb, Inc. | OmniAb, Inc. | EC | 68218J103 | Long | Börsenkurs (Stufe 1) | 2.037.124 $ | 0,02 | 828 | |
| Atea Pharmaceuticals, Inc. | Atea Pharmaceuticals, Inc. | EC | 04683R106 | Long | Börsenkurs (Stufe 1) | 2.036.458 $ | 0,02 | 438 | |
| Lexeo Therapeutics, Inc. | Lexeo Therapeutics, Inc. | EC | 52886X107 | Long | Börsenkurs (Stufe 1) | 2.025.172 $ | 0,02 | 435 | |
| Immuneering Corp. | Immuneering Corp., Class A | EC | 45254E107 | Long | Börsenkurs (Stufe 1) | 1.934.014 $ | 0,02 | 388 | |
| Upstream Bio, Inc. | Upstream Bio, Inc. | EC | 91678A107 | Long | Börsenkurs (Stufe 1) | 1.772.420 $ | 0,02 | 256 | |
| Lineage Cell Therapeutics, Inc. | Lineage Cell Therapeutics, Inc. | EC | 53566P109 | Long | Börsenkurs (Stufe 1) | 1.731.865 $ | 0,02 | 1.322.034 | |
| Anavex Life Sciences Corp. | Anavex Life Sciences Corp. | EC | 032797300 | Long | Börsenkurs (Stufe 1) | 1.636.227 $ | 0,02 | 632 | |
| Fulcrum Therapeutics, Inc. | Fulcrum Therapeutics, Inc. | EC | 359616109 | Long | Börsenkurs (Stufe 1) | 1.456.944 $ | 0,02 | 398 | |
| Keros Therapeutics, Inc. | Keros Therapeutics, Inc. | EC | 492327101 | Long | Börsenkurs (Stufe 1) | 1.374.993 $ | 0,02 | 129 | |
| Codexis, Inc. | Codexis, Inc. | EC | 192005106 | Long | Börsenkurs (Stufe 1) | 1.341.669 $ | 0,01 | 594 | |
| Arcturus Therapeutics Holdings, Inc. | Arcturus Therapeutics Holdings, Inc. | EC | 03969T109 | Long | Börsenkurs (Stufe 1) | 1.234.827 $ | 0,01 | 184 | |
| Voyager Therapeutics, Inc. | Voyager Therapeutics, Inc. | EC | 92915B106 | Long | Börsenkurs (Stufe 1) | 1.219.418 $ | 0,01 | 348 | |
| Quanterix Corp. | Quanterix Corp. | EC | 74766Q101 | Long | Börsenkurs (Stufe 1) | 1.211.492 $ | 0,01 | 280 | |
| NovaBridge Biosciences | NovaBridge Biosciences | EC | 44975P103 | Long | Börsenkurs (Stufe 1) | 1.153.193 $ | 0,01 | 591 | |
| Larimar Therapeutics, Inc. | Larimar Therapeutics, Inc. | EC | 517125100 | Long | Börsenkurs (Stufe 1) | 1.130.077 $ | 0,01 | 371 | |
| Pyxis Oncology, Inc. | Pyxis Oncology, Inc. | EC | 747324101 | Long | Börsenkurs (Stufe 1) | 1.127.787 $ | 0,01 | 375 | |
| Humacyte, Inc. | Humacyte, Inc. | EC | 44486Q103 | Long | Börsenkurs (Stufe 1) | 1.124.150 $ | 0,01 | 1.440.479 | |
| Entrada Therapeutics, Inc. | Entrada Therapeutics, Inc. | EC | 29384C108 | Long | Börsenkurs (Stufe 1) | 1.110.477 $ | 0,01 | 151 | |
| Caribou Biosciences, Inc. | Caribou Biosciences, Inc. | EC | 142038108 | Long | Börsenkurs (Stufe 1) | 1.106.332 $ | 0,01 | 629 | |
| Tenaya Therapeutics, Inc. | Tenaya Therapeutics, Inc. | EC | 87990A106 | Long | Börsenkurs (Stufe 1) | 1.101.694 $ | 0,01 | 1.490.588 | |
| LENZ Therapeutics, Inc. | LENZ Therapeutics, Inc. | EC | 52635N103 | Long | Börsenkurs (Stufe 1) | 1.096.314 $ | 0,01 | 193 | |
| Foghorn Therapeutics, Inc. | Foghorn Therapeutics, Inc. | EC | 344174107 | Long | Börsenkurs (Stufe 1) | 1.082.374 $ | 0,01 | 222 | |
| Quantum-Si, Inc. | Quantum-Si, Inc. | EC | 74765K105 | Long | Börsenkurs (Stufe 1) | 1.060.109 $ | 0,01 | 1.197.863 | |
| AC Immune SA | AC Immune SA | EC | CH0329023102 | Long | Börsenkurs (Stufe 1) | 1.030.226 $ | 0,01 | 433 | |
| Bicycle Therapeutics plc | Bicycle Therapeutics plc | EC | 088786108 | Long | Börsenkurs (Stufe 1) | 1.028.526 $ | 0,01 | 243 | |
| Neumora Therapeutics, Inc. | Neumora Therapeutics, Inc. | EC | 640979100 | Long | Börsenkurs (Stufe 1) | 924.064 $ | 0,01 | 544 | |
| PepGen, Inc. | PepGen, Inc. | EC | 713317105 | Long | Börsenkurs (Stufe 1) | 807.334 $ | 0,01 | 449 | |
| Lyell Immunopharma, Inc. | Lyell Immunopharma, Inc. | EC | 55083R203 | Long | Börsenkurs (Stufe 1) | 759.698 $ | 0,01 | 54 | |
| ADC Therapeutics SA | ADC Therapeutics SA | EC | CH0499880968 | Long | Börsenkurs (Stufe 1) | 715.768 $ | 0,01 | 669 | |
| Cellectis SA | Cellectis SA | EC | 15117K103 | Long | Börsenkurs (Stufe 1) | 669.342 $ | 0,01 | 223 | |
| Black Diamond Therapeutics, Inc. | Black Diamond Therapeutics, Inc. | EC | 09203E105 | Long | Börsenkurs (Stufe 1) | 642.165 $ | 0,01 | 347 | |
| Aardvark Therapeutics, Inc. | Aardvark Therapeutics, Inc. | EC | 002942100 | Long | Börsenkurs (Stufe 1) | 513.354 $ | 0,01 | 89 | |
| Alpha Teknova, Inc. | Alpha Teknova, Inc. | EC | 02080L102 | Long | Börsenkurs (Stufe 1) | 438.297 $ | 0,00 | 77 | |
| Jyong Biotech Ltd. | Jyong Biotech Ltd. | EC | KYG831161065 | Long | Börsenkurs (Stufe 1) | 424.783 $ | 0,00 | 205 | |
| Immutep Ltd. | Immutep Ltd. | EC | 45257L108 | Long | Börsenkurs (Stufe 1) | 305.795 $ | 0,00 | 733 | |
| Gossamer Bio, Inc. | Gossamer Bio, Inc. | EC | 38341P102 | Long | Börsenkurs (Stufe 1) | 247.084 $ | 0,00 | 1.501.116 | |
| Third Harmonic Bio, Inc. | Third Harmonic Bio, Inc. | EC | 88427A107 | Long | Schätzwert (Stufe 3) | 1 $ | 0,00 | 134 | |
| 9.076.288.044 $ | 99,88 | 181.834.752 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
aufsichtsrechtlicher Pflichtmeldungen und öffentlicher Register und stellen keine
Bewertung oder Empfehlung zu einzelnen Wertpapieren, Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher Pflichtmeldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.